Payment overview · 2025
General Payments
$3,591.59
45 reported records · 10 companies
Healthcare provider profile · identity verified
John H Potomski, DO CMA
Allopathic & Osteopathic Physicians|Internal Medicine|Geriatric Medicine · MELBOURNE, FL · NPI 1083657183
Verified facts
What the public records show
CMS Open Payments records show John H Potomski, DO CMA received $3,591.59 in general payments during 2025 across 45 reported records.
Teva Pharmaceuticals USA, Inc. accounted for 71.6% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 12 associated products.
A separate comparison found the same explicitly named product in public Medicare Part D data: Ingrezza, Nuplazid.
ACADIA Pharmaceuticals Inc reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported NUPLAZID as an associated drug or biological on 20845 records involving 6448 distinct recipient NPIs. Public Medicare Part D data also shows 77 claims for Nuplazid by this doctor in 2024.
Lilly USA, LLC reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported JARDIANCE as an associated drug or biological on 47708 records involving 23833 distinct recipient NPIs. Public Medicare Part D data also shows 229 claims for Jardiance by this doctor in 2024.
Lilly USA, LLC reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported MOUNJARO as an associated drug or biological on 186719 records involving 66436 distinct recipient NPIs. Public Medicare Part D data also shows 41 claims for Mounjaro by this doctor in 2024.
Lilly USA, LLC reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported TRULICITY as an associated drug or biological on 71 records involving 57 distinct recipient NPIs. Public Medicare Part D data also shows 143 claims for Trulicity by this doctor in 2024.
Neurocrine BioSciences, Inc. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported INGREZZA as an associated drug or biological on 126456 records involving 27390 distinct recipient NPIs. Public Medicare Part D data also shows 14 claims for Ingrezza by this doctor in 2024.
Otsuka America Pharmaceutical, Inc. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported NUEDEXTA as an associated drug or biological on 393 records involving 285 distinct recipient NPIs. Public Medicare Part D data also shows 37 claims for Nuedexta by this doctor in 2024.
Teva Pharmaceuticals USA, Inc. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported AUSTEDO as an associated drug or biological on 28 records involving 15 distinct recipient NPIs. Public Medicare Part D data also shows 17 claims for Austedo by this doctor in 2024.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Teva Pharmaceuticals USA, Inc. | Unresolved — no canonical attribution shown | $2,570.94 | 71.6% | 23 | 2025 |
| Vanda Pharmaceuticals Inc. | Unresolved — no canonical attribution shown | $248.05 | 6.9% | 2 | 2025 |
| Neurocrine BioSciences, Inc. | Unresolved — no canonical attribution shown | $244.61 | 6.8% | 9 | 2025 |
| Lilly USA, LLC | Unresolved — no canonical attribution shown | $179.79 | 5.0% | 3 | 2025 |
| ACADIA Pharmaceuticals Inc | Unresolved — no canonical attribution shown | $114.06 | 3.2% | 2 | 2025 |
| CVRx, Inc. | Unresolved — no canonical attribution shown | $106.09 | 3.0% | 1 | 2025 |
| UCB, Inc. | Unresolved — no canonical attribution shown | $51.67 | 1.4% | 2 | 2025 |
| Axsome Therapeutics, Inc. | Unresolved — no canonical attribution shown | $30.54 | 0.8% | 1 | 2025 |
| Ardelyx, Inc. | Unresolved — no canonical attribution shown | $26.52 | 0.7% | 1 | 2025 |
| Otsuka America Pharmaceutical, Inc. | Unresolved — no canonical attribution shown | $19.32 | 0.5% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Consulting Fee | $2,105.50 | 1 |
| Food and Beverage | $1,486.09 | 44 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| AUSTEDO XR Normalized: austedo xr |
Drug | Teva Pharmaceuticals USA, Inc. | $2,570.94 | 23 | 2025 |
Source payment records
|
|||||
| FANAPT Normalized: fanapt |
Drug | Vanda Pharmaceuticals Inc. | $248.05 | 2 | 2025 |
Source payment records
|
|||||
| INGREZZA Normalized: ingrezza |
Drug | Neurocrine BioSciences, Inc. | $244.61 | 9 | 2025 |
Source payment records
|
|||||
| NUPLAZID Normalized: nuplazid |
Drug | ACADIA Pharmaceuticals Inc | $114.06 | 2 | 2025 |
Source payment records
|
|||||
| Barostim Neo System Normalized: barostim neo system |
Device | CVRx, Inc. | $106.09 | 1 | 2025 |
Source payment records
|
|||||
| AMYVID Normalized: amyvid |
Drug | Lilly USA, LLC | $54.79 | 2 | 2025 |
Source payment records
|
|||||
| KISUNLA Normalized: kisunla |
Drug | Lilly USA, LLC | $54.79 | 2 | 2025 |
Source payment records
|
|||||
| Auvelity Normalized: auvelity |
Drug | Axsome Therapeutics, Inc. | $30.54 | 1 | 2025 |
Source payment records
|
|||||
| IBSRELA Normalized: ibsrela |
Drug | Ardelyx, Inc. | $26.52 | 1 | 2025 |
Source payment records
|
|||||
| Nayzilam Normalized: nayzilam |
Drug | UCB, Inc. | $26.02 | 1 | 2025 |
Source payment records
|
|||||
| Briviact Normalized: briviact |
Drug | UCB, Inc. | $25.65 | 1 | 2025 |
Source payment records
|
|||||
| REXULTI Normalized: rexulti |
Drug | Otsuka America Pharmaceutical, Inc. | $19.32 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
| Open Payments product | Payment year | Part D brand | Part D year | Claims | Match method | Source |
|---|---|---|---|---|---|---|
| INGREZZA ingrezza |
2025 | Ingrezza | 2024 | 14 Beneficiary count suppressed |
exact normalized | Medicare Part D |
| NUPLAZID nuplazid |
2025 | Nuplazid | 2024 | 77 Beneficiary count suppressed |
exact normalized | Medicare Part D |
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
| Paying company | Payment year | Drug reported by same entity | Open Payments evidence | Part D | Claims | Beneficiaries |
|---|---|---|---|---|---|---|
| ACADIA Pharmaceuticals Inc Exact reporting entity; no affiliate inference |
2025 | NUPLAZID open payments reported associated product |
CMS Open Payments — General Payments 20845 supporting records · 6448 recipient NPIs · example record 1247763852 |
Nuplazid · 2024 Exact normalized brand match · 1 Part D row |
77 | suppressed by CMS |
| Lilly USA, LLC Exact reporting entity; no affiliate inference |
2025 | JARDIANCE open payments reported associated product |
CMS Open Payments — General Payments 47708 supporting records · 23833 recipient NPIs · example record 1186464557 |
Jardiance · 2024 Exact normalized brand match · 1 Part D row |
229 | 33 |
| Lilly USA, LLC Exact reporting entity; no affiliate inference |
2025 | MOUNJARO open payments reported associated product |
CMS Open Payments — General Payments 186719 supporting records · 66436 recipient NPIs · example record 1186464455 |
Mounjaro · 2024 Exact normalized brand match · 1 Part D row |
41 | suppressed by CMS |
| Lilly USA, LLC Exact reporting entity; no affiliate inference |
2025 | TRULICITY open payments reported associated product |
CMS Open Payments — General Payments 71 supporting records · 57 recipient NPIs · example record 1186464601 |
Trulicity · 2024 Exact normalized brand match · 1 Part D row |
143 | 16 |
| Neurocrine BioSciences, Inc. Exact reporting entity; no affiliate inference |
2025 | INGREZZA open payments reported associated product |
CMS Open Payments — General Payments 126456 supporting records · 27390 recipient NPIs · example record 1242766729 |
Ingrezza · 2024 Exact normalized brand match · 1 Part D row |
14 | suppressed by CMS |
| Otsuka America Pharmaceutical, Inc. Exact reporting entity; no affiliate inference |
2025 | NUEDEXTA open payments reported associated product |
CMS Open Payments — General Payments 393 supporting records · 285 recipient NPIs · example record 1227268901 |
Nuedexta · 2024 Exact normalized brand match · 1 Part D row |
37 | 14 |
| Teva Pharmaceuticals USA, Inc. Exact reporting entity; no affiliate inference |
2025 | AUSTEDO open payments reported associated product |
CMS Open Payments — General Payments 28 supporting records · 15 recipient NPIs · example record 1247249192 |
Austedo · 2024 Exact normalized brand match · 1 Part D row |
17 | suppressed by CMS |
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Eliquis | Apixaban | 1942 | 183 |
| Atorvastatin Calcium | Atorvastatin Calcium | 1887 | 312 |
| Levothyroxine Sodium | Levothyroxine Sodium | 1641 | 239 |
| Gabapentin | Gabapentin | 1337 | 223 |
| Amlodipine Besylate | Amlodipine Besylate | 1305 | 222 |
| Potassium Chloride | Potassium Chloride | 1295 | 232 |
| Furosemide | Furosemide | 1232 | 266 |
| Metoprolol Tartrate | Metoprolol Tartrate | 956 | 181 |
| Trazodone Hcl | Trazodone Hcl | 927 | 218 |
| Pantoprazole Sodium | Pantoprazole Sodium | 895 | 204 |
| Lisinopril | Lisinopril | 782 | 146 |
| Tamsulosin Hcl | Tamsulosin Hcl | 733 | 124 |
| Divalproex Sodium | Divalproex Sodium | 694 | 141 |
| Xarelto | Rivaroxaban | 668 | 75 |
| Losartan Potassium | Losartan Potassium | 655 | 116 |
| Memantine Hcl | Memantine Hcl | 649 | 105 |
| Entresto | Sacubitril/Valsartan | 614 | 49 |
| Donepezil Hcl | Donepezil Hcl | 571 | 98 |
| Sertraline Hcl | Sertraline Hcl | 554 | 122 |
| Levetiracetam | Levetiracetam | 548 | 76 |
| Metformin Hcl | Metformin Hcl | 542 | 87 |
| Clopidogrel | Clopidogrel Bisulfate | 532 | 89 |
| Metoprolol Succinate | Metoprolol Succinate | 518 | 102 |
| Omeprazole | Omeprazole | 488 | 96 |
| Mirtazapine | Mirtazapine | 481 | 127 |
| Baclofen | Baclofen | 480 | 74 |
| Duloxetine Hcl | Duloxetine Hcl | 446 | 79 |
| Carvedilol | Carvedilol | 443 | 76 |
| Basaglar Kwikpen U-100 | Insulin Glargine,hum.Rec.Anlog | 433 | 41 |
| Hydralazine Hcl | Hydralazine Hcl | 422 | 86 |
| Ondansetron Hcl | Ondansetron Hcl | 399 | 123 |
| Montelukast Sodium | Montelukast Sodium | 393 | 54 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 387 | 69 |
| Lactulose | Lactulose | 330 | 54 |
| Quetiapine Fumarate | Quetiapine Fumarate | 313 | 77 |
| Latanoprost | Latanoprost | 307 | 65 |
| Midodrine Hcl | Midodrine Hcl | 306 | 84 |
| Spironolactone | Spironolactone | 294 | 61 |
| Myrbetriq | Mirabegron | 291 | 26 |
| Buspirone Hcl | Buspirone Hcl | 286 | 53 |
| Ipratropium-Albuterol | Ipratropium/Albuterol Sulfate | 284 | 145 |
| Escitalopram Oxalate | Escitalopram Oxalate | 283 | 61 |
| Methenamine Hippurate | Methenamine Hippurate | 283 | 56 |
| Famotidine | Famotidine | 267 | 72 |
| Linzess | Linaclotide | 267 | 52 |
| Fluoxetine Hcl | Fluoxetine Hcl | 265 | 44 |
| Lidocaine Hcl | Lidocaine Hcl | 264 | 158 |
| Ertapenem | Ertapenem Sodium | 260 | 145 |
| Prednisone | Prednisone | 260 | 79 |
| Doxycycline Hyclate | Doxycycline Hyclate | 256 | 146 |
| Ceftriaxone | Ceftriaxone Sodium | 254 | 129 |
| Diclofenac Sodium | Diclofenac Sodium | 246 | 64 |
| Bumetanide | Bumetanide | 244 | 45 |
| Jardiance | Empagliflozin | 229 | 33 |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 221 | 125 |
| Aptiom | Eslicarbazepine Acetate | 215 | 11 |
| Clonidine Hcl | Clonidine Hcl | 211 | 73 |
| Pravastatin Sodium | Pravastatin Sodium | 203 | 26 |
| Ropinirole Hcl | Ropinirole Hcl | 187 | 29 |
| Allopurinol | Allopurinol | 185 | 34 |
| Amiodarone Hcl | Amiodarone Hcl | 185 | 33 |
| Finasteride | Finasteride | 179 | 26 |
| Tizanidine Hcl | Tizanidine Hcl | 171 | 31 |
| Carbidopa-Levodopa | Carbidopa/Levodopa | 169 | 27 |
| Simvastatin | Simvastatin | 165 | 24 |
| Meloxicam | Meloxicam | 160 | 33 |
| Fluticasone Propionate | Fluticasone Propionate | 155 | 48 |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 155 | 26 |
| Levofloxacin | Levofloxacin | 149 | 85 |
| Tradjenta | Linagliptin | 148 | 12 |
| Azithromycin | Azithromycin | 147 | 99 |
| Trulicity | Dulaglutide | 143 | 16 |
| Insulin Lispro Kwikpen U-100 | Insulin Lispro | 142 | 41 |
| Citalopram Hbr | Citalopram Hydrobromide | 141 | 29 |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 141 | 32 |
| Dexamethasone | Dexamethasone | 139 | 56 |
| Nystatin | Nystatin | 136 | 67 |
| Insulin Aspart Flexpen | Insulin Aspart | 135 | 29 |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 134 | 27 |
| Fiasp Flextouch | Insulin Aspart (Niacinamide) | 133 | 25 |
| Hydrochlorothiazide | Hydrochlorothiazide | 129 | 24 |
| Propranolol Hcl | Propranolol Hcl | 129 | 23 |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 127 | 26 |
| Oxycodone-Acetaminophen | Oxycodone Hcl/Acetaminophen | 127 | 16 |
| Paroxetine Hcl | Paroxetine Hcl | 126 | 24 |
| Methocarbamol | Methocarbamol | 125 | 40 |
| Methylprednisolone | Methylprednisolone | 125 | 74 |
| Cephalexin | Cephalexin | 120 | 62 |
| Oxcarbazepine | Oxcarbazepine | 120 | 29 |
| Insulin Glargine-Yfgn | Insulin Glargine-Yfgn | 117 | 44 |
| Lamotrigine | Lamotrigine | 117 | 20 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 115 | 52 |
| Digoxin | Digoxin | 114 | 24 |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 114 | 78 |
| Tramadol Hcl | Tramadol Hcl | 111 | 23 |
| Clonidine | Clonidine | 109 | 17 |
| Fluconazole | Fluconazole | 109 | 61 |
| Gemtesa | Vibegron | 107 | 13 |
| Aripiprazole | Aripiprazole | 104 | 19 |
| Januvia | Sitagliptin Phosphate | 104 | suppressed |
| Olanzapine | Olanzapine | 104 | 18 |
| Solu-Medrol | Methylprednisolone Sod Succ/Pf | 104 | 66 |
| Alendronate Sodium | Alendronate Sodium | 103 | 23 |
| Insulin Lispro | Insulin Lispro | 101 | 29 |
| Oxycodone Hcl | Oxycodone Hcl | 100 | 23 |
| Diltiazem Hcl | Diltiazem Hcl | 99 | 22 |
| Benztropine Mesylate | Benztropine Mesylate | 97 | 17 |
| Sucralfate | Sucralfate | 97 | 16 |
| Memantine Hcl Er | Memantine Hcl | 96 | 15 |
| Risperidone | Risperidone | 95 | 22 |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 90 | 56 |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 90 | 25 |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 87 | 44 |
| Breo Ellipta | Fluticasone/Vilanterol | 84 | 21 |
| Brimonidine Tartrate | Brimonidine Tartrate | 82 | 18 |
| Valsartan | Valsartan | 82 | 17 |
| Glipizide | Glipizide | 81 | 14 |
| Levemir | Insulin Detemir | 81 | 12 |
| Nifedipine Er | Nifedipine | 81 | 17 |
| Ezetimibe | Ezetimibe | 80 | 13 |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 80 | 33 |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 78 | 15 |
| Nuplazid | Pimavanserin Tartrate | 77 | suppressed |
| Primidone | Primidone | 76 | 15 |
| Atenolol | Atenolol | 72 | 13 |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 72 | 20 |
| Klor-Con 10 | Potassium Chloride | 72 | suppressed |
| Sodium Chloride | 0.9 % Sodium Chloride | 72 | 48 |
| Meclizine Hcl | Meclizine Hcl | 71 | 15 |
| Topiramate | Topiramate | 69 | 12 |
| Novolog Flexpen | Insulin Aspart | 68 | 18 |
| Scopolamine | Scopolamine | 68 | suppressed |
| Cefdinir | Cefdinir | 66 | 53 |
| Lovastatin | Lovastatin | 65 | suppressed |
| Ketoconazole | Ketoconazole | 64 | 32 |
| Roflumilast | Roflumilast | 63 | suppressed |
| Lorazepam | Lorazepam | 62 | 28 |
| Calcitriol | Calcitriol | 61 | suppressed |
| Santyl | Collagenase Clostridium Hist. | 61 | 30 |
| Timolol Maleate | Timolol Maleate | 61 | 11 |
| Enalapril Maleate | Enalapril Maleate | 60 | 11 |
| Enulose | Lactulose | 60 | 12 |
| Anastrozole | Anastrozole | 59 | suppressed |
| Humalog Kwikpen U-100 | Insulin Lispro | 59 | 13 |
| Lubiprostone | Lubiprostone | 59 | 12 |
| Labetalol Hcl | Labetalol Hcl | 58 | 11 |
| Lantus | Insulin Glargine,hum.Rec.Anlog | 58 | 20 |
| Humalog | Insulin Lispro | 56 | 12 |
| Arexvy | Rsvpref3 Antigen/As01e/Pf | 54 | 51 |
| Metoclopramide Hcl | Metoclopramide Hcl | 54 | 14 |
| Nitroglycerin | Nitroglycerin | 54 | 37 |
| Multaq | Dronedarone Hcl | 53 | suppressed |
| Carbamazepine Er | Carbamazepine | 52 | suppressed |
| Levocetirizine Dihydrochloride | Levocetirizine Dihydrochloride | 52 | suppressed |
| Pregabalin | Pregabalin | 52 | 13 |
| Isosorbide Dinitrate | Isosorbide Dinitrate | 51 | 15 |
| Phenytoin Sodium Extended | Phenytoin Sodium Extended | 51 | suppressed |
| Farxiga | Dapagliflozin Propanediol | 47 | suppressed |
| Letrozole | Letrozole | 47 | suppressed |
| Procrit | Epoetin Alfa | 47 | suppressed |
| Dorzolamide-Timolol | Dorzolamide Hcl/Timolol Maleat | 46 | suppressed |
| Metformin Hcl Er | Metformin Hcl | 46 | suppressed |
| Divalproex Sodium Er | Divalproex Sodium | 45 | 16 |
| Movantik | Naloxegol Oxalate | 45 | suppressed |
| Albuterol Sulfate | Albuterol Sulfate | 44 | 19 |
| Bupropion Hcl Sr | Bupropion Hcl | 44 | suppressed |
| Enoxaparin Sodium | Enoxaparin Sodium | 44 | 17 |
| Oxybutynin Chloride | Oxybutynin Chloride | 44 | 14 |
| Pramipexole Dihydrochloride | Pramipexole Di-Hcl | 44 | suppressed |
| Xifaxan | Rifaximin | 44 | suppressed |
| Ammonium Lactate | Ammonium Lactate | 43 | 22 |
| Dicyclomine Hcl | Dicyclomine Hcl | 41 | 16 |
| Estradiol | Estradiol | 41 | suppressed |
| Glimepiride | Glimepiride | 41 | suppressed |
| Mounjaro | Tirzepatide | 41 | suppressed |
| Advair Hfa | Fluticasone Propion/Salmeterol | 40 | suppressed |
| Insulin Aspart | Insulin Aspart | 40 | 13 |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 40 | suppressed |
| Ranolazine Er | Ranolazine | 39 | suppressed |
| Amoxicillin | Amoxicillin | 38 | 18 |
| Brilinta | Ticagrelor | 38 | suppressed |
| Bupropion Xl | Bupropion Hcl | 38 | suppressed |
| Fludrocortisone Acetate | Fludrocortisone Acetate | 38 | suppressed |
| Levemir Flexpen | Insulin Detemir | 38 | suppressed |
| Ozempic | Semaglutide | 38 | suppressed |
| Warfarin Sodium | Warfarin Sodium | 38 | suppressed |
| Lidocaine Hcl | Lidocaine Hcl/Pf | 37 | 29 |
| Lithium Carbonate | Lithium Carbonate | 37 | suppressed |
| Nuedexta | Dextromethorphan Hbr/Quinidine | 37 | 14 |
| Cholestyramine | Cholestyramine (With Sugar) | 36 | 14 |
| Heparin Sodium | Heparin Sodium,porcine | 36 | suppressed |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 36 | suppressed |
| Mupirocin | Mupirocin | 36 | 25 |
| Rivastigmine | Rivastigmine | 35 | suppressed |
| Erythromycin | Erythromycin Base | 34 | 15 |
| Fenofibrate | Fenofibrate Nanocrystallized | 34 | suppressed |
| Symbicort | Budesonide/Formoterol Fumarate | 34 | 13 |
| Amitriptyline Hcl | Amitriptyline Hcl | 33 | suppressed |
| Carbamazepine | Carbamazepine | 33 | suppressed |
| Celecoxib | Celecoxib | 33 | suppressed |
| Clobetasol Propionate | Clobetasol Propionate | 33 | 18 |
| Kerendia | Finerenone | 33 | suppressed |
| Novolin N Flexpen | Insulin Nph Human Isophane | 33 | suppressed |
| Torsemide | Torsemide | 33 | suppressed |
| Valproic Acid | Valproic Acid (As Sodium Salt) | 33 | suppressed |
| Alprazolam | Alprazolam | 32 | suppressed |
| Fluticasone-Vilanterol | Fluticasone/Vilanterol | 32 | 13 |
| Incruse Ellipta | Umeclidinium Bromide | 32 | suppressed |
| Desmopressin Acetate | Desmopressin Acetate | 31 | suppressed |
| Amantadine | Amantadine Hcl | 30 | suppressed |
| Dorzolamide Hcl | Dorzolamide Hcl | 30 | suppressed |
| Gentamicin Sulfate | Gentamicin Sulfate | 30 | 15 |
| Glycopyrrolate | Glycopyrrolate | 30 | suppressed |
| Ibuprofen | Ibuprofen | 29 | 12 |
| Rasagiline Mesylate | Rasagiline Mesylate | 29 | suppressed |
| Ceftriaxone | Ceftriaxone In Is-Osm Dextrose | 28 | 12 |
| Doxazosin Mesylate | Doxazosin Mesylate | 28 | suppressed |
| Doxycycline Monohydrate | Doxycycline Monohydrate | 28 | 23 |
| Galantamine Er | Galantamine Hbr | 28 | suppressed |
| Acetic Acid | Acetic Acid | 27 | suppressed |
| Hydroxychloroquine Sulfate | Hydroxychloroquine Sulfate | 27 | suppressed |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 27 | suppressed |
| Namzaric | Memantine Hcl/Donepezil Hcl | 27 | suppressed |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 27 | 22 |
| Tresiba Flextouch U-200 | Insulin Degludec | 27 | suppressed |
| Trihexyphenidyl Hcl | Trihexyphenidyl Hcl | 27 | suppressed |
| Acyclovir | Acyclovir | 26 | suppressed |
| Cholestyramine Light | Cholestyramine | 26 | suppressed |
| Clotrimazole-Betamethasone | Clotrimazole/Betamethasone Dip | 26 | 14 |
| Prazosin Hcl | Prazosin Hcl | 26 | suppressed |
| Sevelamer Carbonate | Sevelamer Carbonate | 26 | suppressed |
| Sps | Sodium Polystyrene Sulfon/Sorb | 26 | suppressed |
| Synthroid | Levothyroxine Sodium | 26 | suppressed |
| Clindamycin Hcl | Clindamycin Hcl | 25 | 13 |
| Glucagon Emergency Kit | Glucagon | 25 | 16 |
| Lokelma | Sodium Zirconium Cyclosilicate | 24 | suppressed |
| Metronidazole | Metronidazole | 24 | 13 |
| Oxycontin | Oxycodone Hcl | 24 | suppressed |
| Permethrin | Permethrin | 24 | 21 |
| Tobramycin-Dexamethasone | Tobramycin/Dexamethasone | 24 | 16 |
| Vancomycin Hcl | Vancomycin/Water For Inj (Peg) | 24 | suppressed |
| Ventolin Hfa | Albuterol Sulfate | 24 | 11 |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 23 | suppressed |
| Haloperidol | Haloperidol | 23 | 11 |
| Pyridostigmine Bromide | Pyridostigmine Bromide | 23 | suppressed |
| Semglee (Yfgn) Pen | Insulin Glargine-Yfgn | 23 | suppressed |
| Solifenacin Succinate | Solifenacin Succinate | 23 | suppressed |
| Vancomycin Hcl | Vancomycin Hcl | 23 | suppressed |
| Creon | Lipase/Protease/Amylase | 22 | suppressed |
| Dovato | Dolutegravir Sodium/Lamivudine | 22 | suppressed |
| Doxepin Hcl | Doxepin Hcl | 22 | suppressed |
| Hydrocortisone | Hydrocortisone | 22 | suppressed |
| Breyna | Budesonide/Formoterol Fumarate | 21 | suppressed |
| Mometasone Furoate | Mometasone Furoate | 21 | suppressed |
| Nadolol | Nadolol | 21 | suppressed |
| Nitroglycerin Patch | Nitroglycerin | 21 | suppressed |
| Ondansetron Odt | Ondansetron | 21 | 16 |
| Acetazolamide | Acetazolamide | 20 | suppressed |
| Budesonide | Budesonide | 20 | suppressed |
| Flecainide Acetate | Flecainide Acetate | 20 | suppressed |
| Glipizide Er | Glipizide | 20 | suppressed |
| Mirabegron Er | Mirabegron | 20 | suppressed |
| Nyamyc | Nystatin | 20 | 12 |
| Azelastine Hcl | Azelastine Hcl | 19 | suppressed |
| Diltiazem 24hr Er | Diltiazem Hcl | 19 | suppressed |
| Fiasp | Insulin Aspart (Niacinamide) | 19 | suppressed |
| Haloperidol Lactate | Haloperidol Lactate | 19 | 13 |
| Methylprednisolone Acetate | Methylprednisolone Acetate | 19 | 13 |
| Natroba | Spinosad | 19 | 14 |
| Rivastigmine | Rivastigmine Tartrate | 19 | suppressed |
| Sodium Bicarbonate | Sodium Bicarbonate | 19 | suppressed |
| Wixela Inhub | Fluticasone Propion/Salmeterol | 19 | suppressed |
| Xtampza Er | Oxycodone Myristate | 19 | suppressed |
| Bupropion Hcl | Bupropion Hcl | 18 | suppressed |
| Diltiazem 24hr Er (La) | Diltiazem Hcl | 18 | suppressed |
| Ketorolac Tromethamine | Ketorolac Tromethamine | 18 | suppressed |
| Morphine Sulfate | Morphine Sulfate | 18 | suppressed |
| Raloxifene Hcl | Raloxifene Hcl | 18 | suppressed |
| Alphagan P | Brimonidine Tartrate | 17 | suppressed |
| Anoro Ellipta | Umeclidinium Brm/Vilanterol Tr | 17 | suppressed |
| Austedo | Deutetrabenazine | 17 | suppressed |
| Chlorthalidone | Chlorthalidone | 17 | suppressed |
| Combivent Respimat | Ipratropium/Albuterol Sulfate | 17 | suppressed |
| Folic Acid | Folic Acid | 17 | suppressed |
| Polymyxin B Sul-Trimethoprim | Polymyxin B Sulf/Trimethoprim | 17 | 15 |
| Trexall | Methotrexate Sodium | 17 | suppressed |
| Venlafaxine Hcl | Venlafaxine Hcl | 17 | suppressed |
| Dextrose 5%-0.45% Nacl | Dextrose 5 %-0.45 % Sod Chlord | 16 | 15 |
| Fentanyl | Fentanyl | 16 | suppressed |
| Humulin N Kwikpen | Insulin Nph Human Isophane | 16 | suppressed |
| Hydroxyzine Pamoate | Hydroxyzine Pamoate | 16 | suppressed |
| Kapspargo Sprinkle | Metoprolol Succinate | 16 | suppressed |
| Penicillin V Potassium | Penicillin V Potassium | 16 | suppressed |
| Pioglitazone Hcl | Pioglitazone Hcl | 16 | suppressed |
| Sotalol | Sotalol Hcl | 16 | suppressed |
| Fluocinonide | Fluocinonide | 15 | suppressed |
| Fluorometholone | Fluorometholone | 15 | suppressed |
| Promethazine Hcl | Promethazine Hcl | 15 | 11 |
| Sodium Chloride | Sodium Chloride 0.45 % | 15 | 13 |
| Sumatriptan Succinate | Sumatriptan Succinate | 15 | suppressed |
| Terazosin Hcl | Terazosin Hcl | 15 | suppressed |
| Admelog | Insulin Lispro | 14 | suppressed |
| Asenapine Maleate | Asenapine Maleate | 14 | suppressed |
| Benazepril Hcl | Benazepril Hcl | 14 | suppressed |
| Bethanechol Chloride | Bethanechol Chloride | 14 | suppressed |
| Cefepime Hcl | Cefepime Hcl | 14 | suppressed |
| Clozapine | Clozapine | 14 | suppressed |
| Fosfomycin Tromethamine | Fosfomycin Tromethamine | 14 | 12 |
| Ingrezza | Valbenazine Tosylate | 14 | suppressed |
| Invega Sustenna | Paliperidone Palmitate | 14 | suppressed |
| Methotrexate | Methotrexate Sodium | 14 | suppressed |
| Morphine Sulfate Er | Morphine Sulfate | 14 | suppressed |
| Restasis | Cyclosporine | 14 | suppressed |
| Rybelsus | Semaglutide | 14 | suppressed |
| Simbrinza | Brinzolamide/Brimonidine Tart | 14 | suppressed |
| Toprol Xl | Metoprolol Succinate | 14 | suppressed |
| Cefuroxime | Cefuroxime Axetil | 13 | suppressed |
| Eplerenone | Eplerenone | 13 | suppressed |
| Haloperidol Decanoate | Haloperidol Decanoate | 13 | suppressed |
| Insulin Degludec Pen (U-200) | Insulin Degludec | 13 | suppressed |
| Lidocaine | Lidocaine | 13 | suppressed |
| Methimazole | Methimazole | 13 | suppressed |
| Tolterodine Tartrate Er | Tolterodine Tartrate | 13 | suppressed |
| Tramadol Hcl-Acetaminophen | Tramadol Hcl/Acetaminophen | 13 | suppressed |
| Verapamil Hcl | Verapamil Hcl | 13 | suppressed |
| Amlodipine-Valsartan | Amlodipine Besylate/Valsartan | 12 | suppressed |
| Arnuity Ellipta | Fluticasone Furoate | 12 | suppressed |
| Bisoprolol Fumarate | Bisoprolol Fumarate | 12 | suppressed |
| Dabigatran Etexilate | Dabigatran Etexilate Mesylate | 12 | suppressed |
| Fenofibric Acid | Fenofibric Acid (Choline) | 12 | suppressed |
| Insulin Aspart Prot Mix 70-30 | Insulin Aspart Prot/Insuln Asp | 12 | suppressed |
| Linezolid | Linezolid | 12 | suppressed |
| Lumigan | Bimatoprost | 12 | suppressed |
| Novolog | Insulin Aspart | 12 | suppressed |
| Olmesartan Medoxomil | Olmesartan Medoxomil | 12 | suppressed |
| Phenytoin | Phenytoin | 12 | suppressed |
| Retacrit | Epoetin Alfa-Epbx | 12 | suppressed |
| Sildenafil Citrate | Sildenafil Citrate | 12 | suppressed |
| Spinosad | Spinosad | 12 | 11 |
| Sulfasalazine | Sulfasalazine | 12 | suppressed |
| Acetaminophen-Codeine | Acetaminophen With Codeine | 11 | suppressed |
| Betamethasone Dipropionate | Betamethasone Dipropionate | 11 | suppressed |
| Breztri Aerosphere | Budesonide/Glycopyr/Formoterol | 11 | suppressed |
| Bydureon Bcise | Exenatide Microspheres | 11 | suppressed |
| Dapagliflozin | Dapagliflozin Propanediol | 11 | suppressed |
| Dextrose In Water | Dextrose 5 % In Water | 11 | suppressed |
| Fenofibrate | Fenofibrate | 11 | suppressed |
| Ivermectin | Ivermectin | 11 | suppressed |
| Novolog Mix 70-30 | Insulin Aspart Prot/Insuln Asp | 11 | suppressed |
| Proair Respiclick | Albuterol Sulfate | 11 | suppressed |
| Propranolol Hcl Er | Propranolol Hcl | 11 | suppressed |
| Vancomycin Hcl-0.9% Nacl | Vancomycin/0.9 % Sod Chloride | 11 | suppressed |
| Vascepa | Icosapent Ethyl | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $3,591.59 · 45 records | Teva Pharmaceuticals USA, Inc. | AMYVID, AUSTEDO XR, Auvelity, Barostim Neo System, Briviact, FANAPT, IBSRELA, INGREZZA, KISUNLA, NUPLAZID, Nayzilam, REXULTI | 7 | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- What role, if any, does Ingrezza play in your treatment recommendations for me?
- How do you evaluate evidence when you have a financial relationship with ACADIA Pharmaceuticals Inc?
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error